$29 Medical Devices Doubler
to Hit $60—Buy Now

All thanks to its monitoring technology
that’s doubled investors’ money
twice in the past two years

 

Dear Fellow Investor,

The $795 million medical devices company I’m about to name will soon be a $60 stock that you must snap up today for $29.

The stock jumped 214% in the last 24 months and is set to double again in 2017.

If you fail to add this stock to your holdings now, I guarantee you’ll kick yourself for years.

Here’s why:

This little-known medical devices company is on the cusp of accelerating sales as it introduces new remote cardiac monitoring devices, expands into monitoring for chronic conditions beyond the heart, and gets closer to signing major acquisition that will immediately increase revenue by over 50%.

Once this deal gets done, you could see this company’s stock price jump 50% in the next six months and another 100% soon after that.

Given the company’s previous growth, you may be thinking that you’re too late for the train. The opposite is true.

Here’s why:

First, the company monitors over half a million patients a year and supports over 20,000 physicians and sites. It has 29 U.S. patents and 34 international patents.

Second, over 50,000 of its monitoring devices are out in the market. Those devices process over two billion heartbeats a day, and have generated over a million reports to physicians. This all means quicker diagnosis for patients, a better quality of life and lower costs to the health care system. It also means a more stable business.

Third, the acquisition they have announced would not only take out one of their competitors but also add $113 million in annual revenue to their coffers. The impact would increase the company’s revenue by 55% and push up adjusted EBITDA by 30%.

This is why the company’s 24-month 214% rise is just the beginning of a bold new profit run.

Once you see my complete profit profile on this company, you’ll quickly agree.

This Could Be an Easier Double Than Tesla

I’m Timothy Lutts, and that’s a big claim, I know—especially because Tesla has been one of Cabot’s biggest winners with 1,013% gains to date.

But when you see with your own eyes the number of profit triggers this company possesses for Tesla-like growth, then you’ll understand why we added it to our Cabot Small-Cap Confidential 2.0 holdings. And why I’m urging you to do the same thing before it doubles investors’ money again.

Before I name this stock, I want to explain how we’ve been able to find these kind of profit-rich, game-changing small-cap stocks with uncanny accuracy—in virtually all markets and at all times, for more than two decades.

How Innovation and Superior Stock Selection
Can Be Your Ticket to a Small Fortune Too

First, let me say as the chief investment advisor and futurist for the Cabot organization, it’s not just my job to look 10 to 15 years into the future and show you how to profit, it’s my passion.

That’s why I’m always scanning the horizon for world-changing trends while looking for the companies at the forefront of these dramatic changes.

I’m proud to say that over the years this forward-thinking approach has led us to many investing firsts:

  • FIRST to forecast the growth of online retailing, connecting the dots to 1,290% profits in Amazon
  • FIRST to see the solar power revolution on the horizon, collecting 270% profits in First Solar in 18 months
  • FIRST to see and understand the game-changing technological advantages Apple would bring to the world, banking 746% gains before most Americans even knew this company’s name
  • FIRST to alert readers to the revolution in pure-electric cars, handing readers 1,013% gains in Tesla
  • FIRST to see the huge monopoly that XM-Satellite radio was building in its sector, handing investors 396% gains in just under two years.

That’s why we launched Cabot Small-Cap Confidential 2.0 in the first place nine years ago: To bring you more of these ground floor opportunities faster.

I’m proud to say that over the past nine years, we’ve been able to do just that and double our investors’ money 11 times along the way.

The secret to our success can best be compared to the way an MRI scanner takes pictures inside of your body.

But instead of giving you early warning of a potentially life-threatening disease, my system gives you an advance look at the companies and technologies that can make you rich, months and years before they take off.

That’s because our proprietary stock selection system has been designed not only to identify breakout sales, earnings and profit margin expansion factors …

… but also to identify the specific disruptive, game-changing technologies that most analysts miss and that will ensure a company’s market share and technical superiority for years to come.

Frankly, this is how we banked an 1,013% gain in Tesla, a 1,290% windfall in Amazon, a 270% gain in First Solar, a 746% profit in Apple and a 396% gain in XM-Satellite Radio.

In other words, we identified these disruptive technologies in their early stages and held on for the ride.

Why My Newest Recommendation Looks
a Lot Like Tesla in the Early Days

Just as Tesla’s battery breakthrough revolutionized the electric car industry, this company’s remote cardiac monitoring technology is revolutionizing the remote monitoring industry.

REASON: Its remote telemetry (RCT) monitoring technology is expanding beyond heart monitoring into remote diabetes management.

Do you realize what this means?

There are more than 30 million people in the U.S. suffering from diabetes with direct costs of over $245 billion. The monitoring market is $10 billion of it.

Because remote monitoring will give doctors an accurate picture of their patients’ status, they will be more able to accurately assess treatment in real time.

If the company could capture just a 5% market share of this market, it would result in $500 million in annual revenue. At 10%, you’re looking at a $1 billion boost.

That could send the prices soaring 10-fold.

Don’t think that can’t happen, either.

The company is one of the world’s leading providers of cardiac telemetry. As such, they already possess the infrastructure to expand their market base among the 20,000 doctors they already serve.

And the company’s management continues to impress Wall Street. In fact, over the past four years, the revenues have grown by 16%, 29%, 7% and 17%, respectively—with last year being a record year with $208 million in revenue and 85% earnings growth.

When I look at how this company is on the verge of capturing the diabetes management sector, I continue to see comparisons with Tesla and how they reinvented the electric car market.

This is why I strongly believe that this new recommendation could ultimately become our next Tesla, and why I want to give you the name of this company FREE along with a money-back trial subscription to Cabot Small-Cap Confidential 2.0.

Why FREE?

Two reasons:

  1. To show you how profitable it can be to invest in small cap, emerging technology companies right at the beginning of their biggest growth moves AND before they become front-page news, and
  1. To introduce you to our limited-circulation Cabot Small-Cap Confidential 2.0 investment advisory that targets and profits from these opportunities without you risking a dime. That way, you can see for yourself if our long-term emerging stock investing approach is for you.

Why ONLY 24 Hours?

Because many of our Cabot Small-Cap Confidential 2.0 recommendations tend to jump soon after we recommend them, as individual investors, hedge funds and institutional investors who know our time-proven track record and follow our recommendations begin to pile into our stocks.

However, by limiting our offer this way, we can help ensure you’ll grab the next wave of profits before the big money piles in and this stock breaks out again—and so you won’t miss a dime’s worth of profits.

BEST OF ALL

With our CABOT money-back guarantee, there’s no way you can lose either.

Begin here now.

When you do …

You’ll Also Find Ten More Game Changers That Could
Turn $5,000 into $40,000 Over the Next 24 Months

I speak, for example, of …

  • A pure-play provider of one of the world’s most necessary commodities—water. The company has set up a national network of water refill and exchange locations for selling multi-gallon water jugs. It also sells water dispensers for home use.
  • The virtual reality juggernaut whose head advanced micro displays create a wearable HD home theater experience law enforcement and the military use for training and simulation.
  • The cloud-based services company that allows you to access your computer, files and apps from anywhere in the world while instantly backing up your most crucial data.
  • A pure-play provider of small ticket electronic payment solutions for the unattended point-of-sale market.
  • The best provider of the VoIP solution on the market for home and small office use.
  • A fast-growing developer of the software that serves the booming health and wellness industry. Company’s cloud-based subscription software gives businesses all the tools they need to manage day-to-day operations, as well as pursue targeted growth strategies.

These are just six of our 11 current game-changing recommendations that we’re targeting for triple-digit profits over the next 24 months.

Individually, each one controls a disruptive breakthrough technology that will turn its industry upside down no differently than Amazon, First Solar, Tesla, Apple and XM-Satellite radio have in theirs.

Together, they will give you the opportunity to turn every $5,000 you invest now into $30,000, $40,000, $50,000 or more over the next 30 months.

This Is Why We Limit Our Subscribers to Just 500—and Require That Our Investors Not Share, Sell or Redistribute Our High-Profit Recommendations

A quick look at the 1,290%, 1,013%, 746% and 396% profits in Amazon, Tesla, Apple and XM-Satellite Radio explains why.

Truth is, if we were to leave our membership open, then the whole world would know—at the same time—which companies we were investing in and you would not be able to buy them while their prices were cheap or before the hedge funds, pension funds and mutual funds jumped in.

That’s also why we require strict confidentiality from our members.

It is precisely this exclusivity and discretion that have helped my subscribers and readers enjoy so many life-changing gains from many of our incredible past recommendations.

This is how we plan to maintain this edge and keep your wealth growing—by keeping our circulation small and our recommendations private.

If this sounds like the kind of exclusive investing advisory, approach and profits that you’re looking for, you owe it to yourself to accept my incredible offer to get the name of our next Tesla FREE … along with a money-back subscription to Cabot Small-Cap Confidential 2.0.

Here’s What Makes This Opportunity So Rare

Just as we limit our subscription to 500 readers, we must limit this introductory offer to the first 50 who say “Yes” today, because we have only 50 open memberships.

Once those final spots are filled, this service will be closed until the next opening.

Since this is the first time in three years that we’ve sent this offer, I can’t promise that will be anytime soon.

For these reasons, if you don’t take advantage of this opportunity to join us today, you may have to wait another three years to join us.

The reason is simple:

When you consistently deliver these kinds of double- and triple-digit profits year after year, investors stick with you over the long term. We think you will too, or you’ll receive a prompt pro-rated refund—for the first 30 days of your subscription.

My complete, no-questions-asked, “profit first” money-back guarantee gives you the confidence to invest in our emerging growth plays, knowing that you can cancel for a pro-rated refund in the first 30 days.

If you are already a Cabot subscriber, then you know that’s the same “profit first” approach we’ve honored for 46 years on our other advisories. You can count on it here, too, when you join us at Cabot Small-Cap Confidential 2.0.

So if you’ve always wanted to try my Cabot Small-Cap Confidential 2.0. investing advisory, today is the day.

By simply saying “Yes” to this 100% risk-free opportunity, you’ll get the chance to invest in the next Tesla.

Your low introductory price includes:

  • A monthly market update that will bring you a panoramic view of what’s going on in the market and how it affects our events along with weekly news updates and flash alerts on the stocks that we own and any adjustments for your portfolio
  • Institutional-level profit profiles of the exciting new first-mover companies we’re targeting for profits.
  • Weekly updates that will explain how the week’s market changes, government economic reports, earnings releases and/or competitive technologies will affect our investments
  • Cabot Small-Cap Confidential 2.0 private website, featuring the most recent issue, annual forecast issue and special reports, along with an archive of our past issues and reports
  • Personalized investor relations staff to answer your questions every day the market is open.
  • Tyler Laundon’s private email address to write him directly should you have any questions about his forecasts or recommendations, along with the promise you will receive a written response directly from him or our staff within 48 hours
  • PLUS my satisfaction guarantee that covers you for the first 30 days of your subscription. Just let us know if you are not satisfied and we’ll refund the balance of your subscription within the first 30 days.

This is how Cabot Small-Cap Confidential 2.0 has become one of the most respected and profitable investment advisories on Wall Street.

As our long-term track record clearly shows, you really can invest in and profit from game-changing companies and technologies when you spot them early and have the patience to hold on for the ride as we do.

My “profit first” money-back guarantee promises just that.

By joining us ahead of our 24-hour deadline, you’ll also lock in our best price.

Join Today to Get the Name of My Next Tesla
Sent Directly to Your Inbox Free

But you’ll need to hurry.

The last time we sent a similar offer to our Cabot family of readers, all our available slots were filled in less than 24 hours.

With our special low pricing, I expect that same thing to happen this time as well.

So what are you waiting for?

Join us now here at Cabot Small-Cap Confidential 2.0. today.

  • Check out the explosive profits our small-cap stocks can hand you.
  • See how exciting it feels to turn $5,000 into $55,650 in the next 30 months.
  • Take FULL advantage of my 100% satisfaction guarantee to decide if Cabot Small-Cap Confidential 2.0 is for you.

Mark my words: Once you grab your first 100% gain, I’ll bet I couldn’t pry your subscription from your hand if I tried.

Begin here now.

I guarantee it will be one of the most profitable investing decisions of your investing life.

Sincerely,

Tim-signature

Tim Lutts, Chief Investment Officer
Cabot Small-Cap Confidential 2.0

P.S. I’ll never forget the day we saw Tesla give us a 1,013% gain and my readers saw a $5,000 investment soar to $55,650!

Or the day I sold Amazon for a 1,290% gain or Apple for a 746% gain or XM-Satellite Radio for a 396% profit.

I know you’ll feel 10-feet tall and bulletproof too, when you get in on the ground floor of my next First Solar TONIGHT and take profits with us here as well.

That’s why I’ve made it as easy as possible for our loyal Cabot readers to give Cabot Small-Cap Confidential 2.0 a try.

That way you can see the difference our small cap emerging growth stock advisory can make for your future—and without any risk or obligation to continue if you’re not 100% satisfied with your profits.

That’s why we expect our final open spaces to sell out long before tomorrow’s 24-hour deadline.

Trust your impulse and let your destiny unfold. Join us now here at Cabot Small-Cap Confidential 2.0 today. You have nothing to lose and everything to gain.